UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 111

Sortiert nach

Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2008-07, Vol.26 (21), p.3543-3551

2008

Link zum Volltext

Verfügbarkeit prüfen

Molecular biomarkers in non-small-cell lung cancer: a retrospective analysis of data from the phase 3 FLEX study

The lancet oncology, 2011-08, Vol.12 (8), p.795-805

2011

Link zum Volltext

Verfügbarkeit prüfen

Phase III Study of Erlotinib in Combination With Cisplatin and Gemcitabine in Advanced Non–Small-Cell Lung Cancer: The Tarceva Lung Cancer Investigation Trial

Journal of clinical oncology, 2007-04, Vol.25 (12), p.1545-1552

2007

Link zum Volltext

Verfügbarkeit prüfen

Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma

Journal of clinical oncology, 2003-07, Vol.21 (14), p.2636-2644

2003

Link zum Volltext

Verfügbarkeit prüfen

Lactate dehydrogenase as prognostic factor in limited and extensive disease stage small cell lung cancer – A retrospective single institution analysis

Respiratory medicine, 2010-12, Vol.104 (12), p.1937-1942

2010

Link zum Volltext

Verfügbarkeit prüfen

Phase II, Multicenter, Uncontrolled Trial of Single-Agent Sorafenib in Patients With Relapsed or Refractory, Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2009-09, Vol.27 (26), p.4274-4280

2009

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy

Journal of clinical oncology, 2004-05, Vol.22 (9), p.1589-1597

2004

Link zum Volltext

Verfügbarkeit prüfen

Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 1

Journal of clinical oncology, 2004-03, Vol.22 (5), p.777-784

2004

Link zum Volltext

Verfügbarkeit prüfen

First-cycle rash and survival in patients with advanced non-small-cell lung cancer receiving cetuximab in combination with first-line chemotherapy: a subgroup analysis of data from the FLEX phase 3 study

The lancet oncology, 2011, Vol.12 (1), p.30-37

2011

Link zum Volltext

Verfügbarkeit prüfen

Phase III Study of Matrix Metalloproteinase Inhibitor Prinomastat in Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2005-02, Vol.23 (4), p.842-849

2005

Link zum Volltext

Verfügbarkeit prüfen

A Phase II Pharmacodynamic Study of Erlotinib in Patients with Advanced Non–Small Cell Lung Cancer Previously Treated with Platinum-Based Chemotherapy

Clinical cancer research, 2008-06, Vol.14 (12), p.3867-3874

2008

Link zum Volltext

Verfügbarkeit prüfen

Phase III Trial Comparing Carboplatin, Paclitaxel, and Bexarotene With Carboplatin and Paclitaxel in Chemotherapy-Naïve Patients With Advanced or Metastatic Non–Small-Cell Lung Cancer: SPIRIT II

Journal of clinical oncology, 2008-04, Vol.26 (11), p.1879-1885

2008

Link zum Volltext

Verfügbarkeit prüfen

Phase II Comparator Study of Oral Versus Intravenous Topotecan in Patients With Chemosensitive Small-Cell Lung Cancer

Journal of clinical oncology, 2001-03, Vol.19 (6), p.1743-1749

2001

Link zum Volltext

Verfügbarkeit prüfen

Tirapazamine Plus Cisplatin Versus Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Report of the International CATAPULT I Study Group

Journal of clinical oncology, , Vol.18 (6), p.1351-1359

Link zum Volltext

Verfügbarkeit prüfen

Adenovirus-Mediated Wild-Type p53 Gene Transfer in Patients Receiving Chemotherapy for Advanced Non–Small-Cell Lung Cancer: Results of a Multicenter Phase II Study

Journal of clinical oncology, 2001-03, Vol.19 (6), p.1750-1758

2001

Link zum Volltext

Verfügbarkeit prüfen

Phase III Comparative Study of High-Dose Cisplatin Versus a Combination of Paclitaxel and Cisplatin in Patients With Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2000-10, Vol.18 (19), p.3390-3399

2000

Link zum Volltext

Verfügbarkeit prüfen

Incidence of febrile neutropenia and myelotoxicity of chemotherapy: a meta-analysis of biosimilar G-CSF studies in breast cancer, lung cancer, and non-Hodgkin's lymphoma

Onkologie, 2009-10, Vol.32 (10), p.599-604

2009

Link zum Volltext

Verfügbarkeit prüfen

Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma

Journal of clinical oncology, 2023-04, Vol.41 (12), p.2125-2133

2023

Link zum Volltext

Verfügbarkeit prüfen

Randomized phase II trial of gemcitabine–cisplatin with or without trastuzumab in HER2-positive non-small-cell lung cancer

Annals of oncology, 2004-01, Vol.15 (1), p.19-27

2004

Link zum Volltext

Verfügbarkeit prüfen

Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial

The Lancet (British edition), 2009-05, Vol.373 (9674), p.1525-1531

2009

Link zum Volltext

Verfügbarkeit prüfen

Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2023-05, Vol.41 (14), p.2458-2466

2023

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy

Journal of clinical oncology, 2023-05, Vol.41 (15), p.2682-2690

2023

Link zum Volltext

Verfügbarkeit prüfen

Targeted therapies Thalidomide in lung cancer therapy-what have we learned?

Nature reviews. Clinical oncology, 2010-03, Vol.7 (3), p.134-135

2010

Link zum Volltext

Verfügbarkeit prüfen

E03-01: New cytotoxics

Journal of thoracic oncology, 2007-08, Vol.2 (8), p.S219-S220

Gatzemeier, Ulrich

2007

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 111

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(98)
Mit Volltextzugriff
(99)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(67)
Life Sciences & Biomedicine
(64)
Science & Technology
(64)
Oncology
(54)
Lung Neoplasms - Drug Therapy
(50)
Male
(48)
Female
(46)
Middle Aged
(45)
Aged
(44)
Adult
(38)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(38)
Biological And Medical Sciences
(37)
Medical Sciences
(36)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(33)
Lung Neoplasms - Pathology
(32)
Treatment Outcome
(30)
Chemotherapy
(24)
Neoplasm Staging
(22)
Pneumology
(22)
Tumors Of The Respiratory System And Mediastinum
(21)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer

Molecular biomarkers in non-small-cell lung cancer: a retrospective analysis of data from the phase 3 FLEX study

Phase III Study of Erlotinib in Combination With Cisplatin and Gemcitabine in Advanced Non–Small-Cell Lung Cancer: The Tarceva Lung Cancer Investigation Trial

Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma

Lactate dehydrogenase as prognostic factor in limited and extensive disease stage small cell lung cancer – A retrospective single institution analysis

Phase II, Multicenter, Uncontrolled Trial of Single-Agent Sorafenib in Patients With Relapsed or Refractory, Advanced Non–Small-Cell Lung Cancer

Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy

Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 1

First-cycle rash and survival in patients with advanced non-small-cell lung cancer receiving cetuximab in combination with first-line chemotherapy: a subgroup analysis of data from the FLEX phase 3 study

Phase III Study of Matrix Metalloproteinase Inhibitor Prinomastat in Non–Small-Cell Lung Cancer

A Phase II Pharmacodynamic Study of Erlotinib in Patients with Advanced Non–Small Cell Lung Cancer Previously Treated with Platinum-Based Chemotherapy

Randomized Phase III Study of Matrix Metalloproteinase Inhibitor BMS-275291 in Combination With Paclitaxel and Carboplatin in Advanced Non-Small-Cell Lung Cancer: National Cancer Institute of Canada-Clinical Trials Group Study BR.18

Phase III Trial Comparing Carboplatin, Paclitaxel, and Bexarotene With Carboplatin and Paclitaxel in Chemotherapy-Naïve Patients With Advanced or Metastatic Non–Small-Cell Lung Cancer: SPIRIT II

Phase II Comparator Study of Oral Versus Intravenous Topotecan in Patients With Chemosensitive Small-Cell Lung Cancer

Tirapazamine Plus Cisplatin Versus Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Report of the International CATAPULT I Study Group

Adenovirus-Mediated Wild-Type p53 Gene Transfer in Patients Receiving Chemotherapy for Advanced Non–Small-Cell Lung Cancer: Results of a Multicenter Phase II Study

Phase III Comparative Study of High-Dose Cisplatin Versus a Combination of Paclitaxel and Cisplatin in Patients With Advanced Non–Small-Cell Lung Cancer

Incidence of febrile neutropenia and myelotoxicity of chemotherapy: a meta-analysis of biosimilar G-CSF studies in breast cancer, lung cancer, and non-Hodgkin's lymphoma

Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma

Randomized phase II trial of gemcitabine–cisplatin with or without trastuzumab in HER2-positive non-small-cell lung cancer

Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial

Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non-Small-Cell Lung Cancer

Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy

Targeted therapies Thalidomide in lung cancer therapy-what have we learned?

E03-01: New cytotoxics

Suchergebnisse filtern